• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估抗原阳性毒素阴性酶免疫测定结果用于诊断产毒素艰难梭菌感染

Evaluation of antigen-positive toxin-negative enzyme immunoassay results for the diagnosis of toxigenic Clostridium difficile infection.

作者信息

Akamatsu Yukinobu, Morishita Shota, Chikumi Hiroki, Okamoto Ryo, Okada Kensaku, Kitaura Tsuyoshi, Miyake Naomi, Yamaguchi Kosuke, Nakamoto Masaki, Shimohiro Hisashi, Takata Miyako, Yamasaki Akira, Burioka Naoto, Shimizu Eiji

机构信息

Center for Infectious diseases, Tottori University Hospital.

Division of Clinical Laboratory, Tottori University Hospital.

出版信息

J Med Invest. 2018;65(1.2):131-135. doi: 10.2152/jmi.65.131.

DOI:10.2152/jmi.65.131
PMID:29593183
Abstract

Clostridium difficile (C. difficile)-associated diarrhea (CDAD) is a challenging nosocomial infectious disease. C. DIFF Quik Chek Complete assay is widely used to detect glutamate dehydrogenase (GDH) antigen and toxin A/B of C. difficile simultaneously. However, the interpretation of GDH positive/toxin negative results is problematic. We performed a retrospective study of patients with GDH positive/toxin negative results to determine the probability of detecting toxigenic C. difficile and its risk factors. Between April 2012 and March 2017, we investigated cultures of fecal specimens followed by toxin detection tests. The clinical histories of patients with and without toxigenic C. difficile were compared using univariate- and multivariate-analyses. In total, 2675 patients were examined using C. Diff Quik Chek Complete assay. Among 356 GDH positive/toxin negative patients, cultures were performed in 220 cases and toxigenic C. difficile was recovered from 139 (63.2%) specimens. Patients with toxigenic C. difficile had significantly lower body mass index than those without. Over half the GDH positive/toxin negative patients were infected with toxigenic C. difficile. Lower BMI was a CDAD risk factor in this patient population. These data can be utilized to initiate isolation and clinical interventions before confirmatory test results are available. J. Med. Invest. 65:131-135, February, 2018.

摘要

艰难梭菌相关性腹泻(CDAD)是一种具有挑战性的医院感染性疾病。艰难梭菌快速检测综合检测法被广泛用于同时检测艰难梭菌的谷氨酸脱氢酶(GDH)抗原和毒素A/B。然而,GDH阳性/毒素阴性结果的解读存在问题。我们对GDH阳性/毒素阴性结果的患者进行了一项回顾性研究,以确定检测产毒艰难梭菌的概率及其危险因素。在2012年4月至2017年3月期间,我们对粪便标本进行培养,随后进行毒素检测试验。使用单因素和多因素分析比较了有无产毒艰难梭菌患者的临床病史。总共2675例患者使用艰难梭菌快速检测综合检测法进行了检查。在356例GDH阳性/毒素阴性患者中,220例进行了培养,139例(63.2%)标本中分离出产毒艰难梭菌。产毒艰难梭菌患者的体重指数显著低于无产毒艰难梭菌患者。超过一半的GDH阳性/毒素阴性患者感染了产毒艰难梭菌。较低的体重指数是该患者群体中CDAD的一个危险因素。这些数据可用于在获得确诊检测结果之前启动隔离和临床干预措施。《医学调查杂志》65:131 - 135,2018年2月。

相似文献

1
Evaluation of antigen-positive toxin-negative enzyme immunoassay results for the diagnosis of toxigenic Clostridium difficile infection.评估抗原阳性毒素阴性酶免疫测定结果用于诊断产毒素艰难梭菌感染
J Med Invest. 2018;65(1.2):131-135. doi: 10.2152/jmi.65.131.
2
Evaluation of Risk Factors for Clostridium difficile Infection Based on Immunochromatography Testing and Toxigenic Culture Assay.基于免疫胶体金渗滤法检测和产毒培养检测对艰难梭菌感染危险因素的评估。
J Clin Microbiol. 2018 Nov 27;56(12). doi: 10.1128/JCM.00555-18. Print 2018 Dec.
3
Impact of simultaneous glutamate dehydrogenase and toxin A/B rapid immunoassay on Clostridium difficile diagnosis and treatment in hospitalized patients with antibiotic-associated diarrhea in a university hospital of Brazil.巴西某大学附属医院住院患者抗生素相关性腹泻中同时进行谷氨酸脱氢酶和毒素 A/B 快速免疫测定对艰难梭菌诊断和治疗的影响。
J Gastroenterol Hepatol. 2018 Feb;33(2):393-396. doi: 10.1111/jgh.13901.
4
Evaluation of a simultaneous detection kit for the glutamate dehydrogenase antigen and toxin A/B in feces for diagnosis of Clostridium difficile infection.评估粪便中谷氨酸脱氢酶抗原和毒素 A/B 的同时检测试剂盒用于诊断艰难梭菌感染。
J Infect Chemother. 2011 Dec;17(6):807-11. doi: 10.1007/s10156-011-0267-5. Epub 2011 Jul 2.
5
Simultaneous Detection of Glutamate Dehydrogenase and Toxin A/B: Comparison of the C. DIFF QUIK CHEK COMPLETE and RIDASCREEN Assays.同时检测谷氨酸脱氢酶和毒素 A/B:C. DIFF QUIK CHEK COMPLETE 和 RIDASCREEN 检测方法的比较。
Ann Lab Med. 2019 Mar;39(2):214-217. doi: 10.3343/alm.2019.39.2.214.
6
Evaluation of a rapid membrane enzyme immunoassay for the simultaneous detection of glutamate dehydrogenase and toxin for the diagnosis of Clostridium difficile infection.评估一种用于同时检测谷氨酸脱氢酶和毒素以诊断艰难梭菌感染的快速膜酶免疫测定法。
Ann Lab Med. 2014 May;34(3):235-9. doi: 10.3343/alm.2014.34.3.235. Epub 2014 Apr 8.
7
[Diagnosis of Clostridium difficile infections: comparative study of two immuno enzyme assays with confirmation by PCR and culture followed by PCR ribotyping].[艰难梭菌感染的诊断:两种免疫酶测定法与经聚合酶链反应(PCR)和培养确认并随后进行PCR核糖分型的比较研究]
Epidemiol Mikrobiol Imunol. 2014 Jun;63(2):99-102.
8
High Agreement Between an Ultrasensitive Clostridioides difficile Toxin Assay and a C. difficile Laboratory Algorithm Utilizing GDH-and-Toxin Enzyme Immunoassays and Cytotoxin Testing.高敏艰难梭菌毒素检测与应用谷氨酸脱氢酶和毒素酶联免疫吸附试验及细胞毒素检测的艰难梭菌实验室算法的高度一致性。
J Clin Microbiol. 2020 Jan 28;58(2). doi: 10.1128/JCM.01629-19.
9
Performance of TechLab C. DIFF QUIK CHEK and TechLab C. DIFFICILE TOX A/B II for the detection of Clostridium difficile in stool samples.TechLab艰难梭菌快速检测试剂盒和TechLab艰难梭菌毒素A/B II检测试剂盒在粪便样本中检测艰难梭菌的性能。
Diagn Microbiol Infect Dis. 2007 Sep;59(1):33-7. doi: 10.1016/j.diagmicrobio.2007.04.018. Epub 2007 Jul 26.
10
Comparison of BD GeneOhm Cdiff real-time PCR assay with a two-step algorithm and a toxin A/B enzyme-linked immunosorbent assay for diagnosis of toxigenic Clostridium difficile infection.BD GeneOhm Cdiff 实时 PCR 检测法与两步法算法和毒素 A/B 酶联免疫吸附试验比较,用于诊断产毒艰难梭菌感染。
J Clin Microbiol. 2010 Jan;48(1):109-14. doi: 10.1128/JCM.01630-09. Epub 2009 Oct 28.

引用本文的文献

1
Antimicrobial Resistance and Associated Risk Factors for in Patients Attending Tertiary Care Settings.三级医疗机构患者的抗菌药物耐药性及相关危险因素
J Trop Med. 2024 May 16;2024:6613120. doi: 10.1155/2024/6613120. eCollection 2024.
2
Prevalence of diagnostically-discrepant clinical specimens: insights from longitudinal surveillance.诊断结果存在差异的临床标本的流行情况:纵向监测的见解
Front Med (Lausanne). 2023 Oct 18;10:1238159. doi: 10.3389/fmed.2023.1238159. eCollection 2023.